Cite
HARVARD Citation
Vela, M. et al. (2020). Donor's graft ex vivo T‐cell depletion with fludarabine reduces graft‐versus‐host disease signs and improves survival after intestinal transplantation – an experimental study. Transplant international. pp. 1302-1311. [Online].